Skip to main content

Table 1 Characteristic of subjects (mean ± SD)

From: Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

 

male/female

age

height (cm)

weight (kg)

BMI

PBC

2/8

52.10 ± 11.10

164.30 ± 6.88

66.15 ± 10.15

24.41 ± 2.61

Control

3/7

47.20 ± 8.60

166.90 ± 8.63

66.10 ± 7.92

23.73 ± 1.87

  1. P1 is PBC patients (pretreatment) compared with controls, *p < 0.05.